1-3 of 3
Helene Lapillone
Close
Sort by
Journal Articles

A Transcriptional- and Posttranscriptional-Based Prognostic Model in Pediatric Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Lea Herpe, Christine Ragu, PhD, Franck Mortreux, PhD, Yves Bertrand, MD PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2870.
https://doi.org/10.1182/blood.V128.22.2870.2870
Published: 2016
Journal Articles

Age and Gemtuzumab Ozogamicin Influence the Prognostic Impact of TET2 Expression and Splicing in Intensively Treated Patients with Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Xavier Thomas, MD PhD, Olivier Nibourel, PharmD, PhD, Claude Preudhomme, MD PhD, Sylvie Castaigne, MD PhD, Hervé Dombret, Lea Herpe, Christine Ragu, PhD, Yves Bertrand, MD PhD, Franck Mortreux, PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3952.
https://doi.org/10.1182/blood.V128.22.3952.3952
Published: 2016
Journal Articles

Prognostic Impact of ABCA3 Expression in Pediatric Acute Myeloid Leukemia

Antony Ceraulo, Aminetou Mint-Mohamed, Delphine Maucort-Boulch, MD PhD, Helene Lapillone, Guy Leverger, MD, Etienne Paubelle, MD PhD, Lea Herpe, Catherine Koering, PhD, Christine Ragu, PhD, Yves Bertrand, MD PhD, Eric Wattel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1694.
https://doi.org/10.1182/blood.V128.22.1694.1694
Published: 2016